← Back to headlines
Sarepta Therapeutics Stock Rises on Positive Muscular Dystrophy Therapy Data
Sarepta Therapeutics saw its stock increase following the release of positive data concerning its therapies for muscular dystrophy.
25 Mar, 13:49 — 25 Mar, 13:49
Sources
Showing 1 of 1 sources
Related Stories
University of Pretoria Study Challenges Wildlife Decline Narrative
12m ago
NASA Selects Photo by Bulgarian Astrophotographer Rositsa Dimitrova as 'Picture of the Day'
13m ago
Dutch Immunologists Discover Auto-Antibody Link to Long Covid, Propose Blood Filtering Treatment
14m ago
Trump Appoints Tech Leaders Zuckerberg, Brin, and Huang to Science Council
23m ago